General Information
Drug ID
DR00146
Drug Name
Deflazacort
Synonyms
Deflan (TN)
Drug Type
Small molecular drug
Indication Duchenne muscular dystrophy [ICD11: 8C70.1] Approved [1]
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=26709"></iframe>
3D MOL 2D MOL
Formula
C25H31NO6
Canonical SMILES
CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)C<br />OC(=O)C
InChI
InChI=1S/C25H31NO6/c1-13-26-25(20(30)12-31-14(2)27)21(32-13)10-18-17-6-5-15-9-16(28)7-8-23(15,3)22(17)19(29)11-24(18,25)4/h7-9,17-19,21-22,29H,5-6,10-12H2,1-4H3
InChIKey
FBHSPRKOSMHSIF-UHFFFAOYSA-N
CAS Number
CAS 14484-47-0
Pharmaceutical Properties Molecular Weight 441.524 Topological Polar Surface Area 102
Heavy Atom Count 32 Rotatable Bond Count 4
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 7
PubChem CID
26709
PubChem SID
104298055 , 125341126 , 126667087 , 136298778 , 137231389 , 163133908 , 164788299 , 223659443 , 226396091 , 251887654 , 29293537 , 50019505 , 57310307 , 78434559 , 81041118
ChEBI ID
CHEBI:135720
TTD Drug ID
D09WYX
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Deflazacort was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01665)

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.